A detailed history of Sym Financial Corp transactions in Incyte Corp stock. As of the latest transaction made, Sym Financial Corp holds 5,524 shares of INCY stock, worth $575,324. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,524
Previous 6,565 15.86%
Holding current value
$575,324
Previous $447,000 4.7%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

SELL
$67.27 - $86.96 $70,028 - $90,525
-1,041 Reduced 15.86%
5,524 $468,000
Q2 2025

Aug 01, 2025

SELL
$55.17 - $71.22 $21,902 - $28,274
-397 Reduced 5.7%
6,565 $447,000
Q1 2025

May 06, 2025

BUY
$60.0 - $75.26 $94,560 - $118,609
1,576 Added 29.26%
6,962 $421,000
Q4 2024

Jan 24, 2025

BUY
$65.08 - $83.38 $350,520 - $449,084
5,386 New
5,386 $372,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sym Financial Corp Portfolio

Follow Sym Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sym Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sym Financial Corp with notifications on news.